Your browser doesn't support javascript. This means that the content or functionality of our website will be limited or unavailable. If you need more information about Vinnova, please contact us.

To main content To sitemap To news Check availability details

Novel therapies in mucoploysaccaridosis

Reference number
Coordinator Axcentua Pharmaceuticals AB
Funding from Vinnova SEK 75 000
Project duration August 2011 - November 2011
Status Completed

Last updated 25 November 2019

Reference number 2011-03543

Page statistics